SNU-449 Cells
USUSD$550.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | SNU-449 is a human hepatocellular carcinoma (HCC) cell line widely used in research to study liver cancer biology, drug resistance, apoptosis, and novel therapeutic strategies. As hepatocellular carcinoma is one of the most aggressive and common liver malignancies with poor prognosis, cell lines like SNU-449 are critical for understanding the molecular mechanisms underlying cancer progression and drug responses. SNU-449 has been particularly useful in studies involving apoptosis and ferroptosis, a regulated form of cell death associated with iron-dependent lipid peroxidation. For example, research has shown that agents like sorafenib, a standard treatment for advanced HCC, and artesunate synergize to induce ferroptosis in SNU-449 cells. This combination exacerbates lipid peroxidation and oxidative stress, leading to extensive cancer cell death. This synergy occurs because artesunate promotes lysosomal ferritin degradation (ferritinophagy), which increases free iron availability, while sorafenib impairs mitochondrial function and depletes glutathione, a critical antioxidant. SNU-449 has also been used to explore apoptotic pathways in liver cancer. For example, genistein, a natural isoflavone, induces apoptosis in SNU-449 cells by down-regulating thioredoxin-1 (Trx1), an antioxidant protein that regulates reactive oxygen species (ROS) and inhibits apoptosis. Genistein treatment increases ROS levels and activates apoptosis-related pathways, including caspase-3 activation and DNA fragmentation. These findings highlight SNU-449 as a valuable model for studying both apoptosis and ferroptosis, aiding in the development of targeted therapies for hepatocellular carcinoma. |
|---|---|
| 生物體 | Human |
| 組織 | Liver |
| 疾病 | Adult hepatocellular carcinoma |
| 同義詞 | SNU449, NCI-SNU-449 |
特徵
| 年齡 | 52 years |
|---|---|
| 性別 | Male |
| 族裔 | Korean |
| 形態學 | Epithelial-like |
| 生長特性 | Adherent |
監管數據
| 引用 | SNU-449 (Cytion catalog number 305429) |
|---|---|
| 生物安全等級 | 2 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_0454 |
生物分子資料
| 病毒 | HBV |
|---|---|
| 突變譜 | Mutation: ARID1A, p.Glu2250Argfs*28 (c.6747dupA); Mutation: AXIN1, p.Arg712Ter (c.2134C>T), homozygous; Mutation: TP53, p.Lys139Arg (c.416A>G); Mutation: TP53, p.Ala161Thr (c.481G>A), homozygous |
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% heat-inactivated FBS, add 2.5 g/L glucose and 25 mM HEPES |
| 解離試劑 | Accutase |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305429-270924 | 分析證明書 | 23. May. 2025 | 305429 |
| 305429-130226 | 分析證明書 | 13. Mar. 2026 | 305429 |
-
Related products
Related products